1536053-91-4

Upstream product

• 1536053-88-9 (3S,4R)-5-(dimethyl(phenyl)silyl)-1-(4-methoxybenzyloxy)-4-methylhex-5-en-3-ol 
• 103223-44-5 (buta-1,3-dien-2-yl)dimethyl(phenyl)silane 
• 135362-69-5 3-(4-methoxybenzyl)oxypropan-1-ol 

Downstream Products

• 1536053-93-6 C₂₃H₃₀Br₂O₃Si 
• 1536053-95-8 (2S,4S)-4-((R)-3-bromobut-3-en-2-yl)-2-(4-methoxyphenyl)-1,3-dioxane 
• 1536054-10-0 (2S,5S)-1-((4S,6S)-6-(benzyloxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)-4-methylenehexan-2-ol 
• 1536054-12-2 ((2S,5S)-1-((4R,6S)-6-(benzyloxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)-4-methylenehexan-2-yloxy)(tert-butyl)dimethylsilane 
• 1536054-15-5 (2R,5R)-6-((4R,6S)-6-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((tert-butyldimethylsilyl)oxy)-2-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)hexan-3-one 

Relevant academic research and scientific papers

Asymmetric alcohol C-H allylation and syn -Crotylation: C9-C20 of tetrafibricin

The C9-C20 segment of the fibrinogen receptor inhibitor tetrafibricin was prepared in 10 steps (longest linear sequence). Ruthenium catalyzed enantioselective syn-crotylation is used to construct C9-C13. Iridium catalyzed asymmetric alcohol C-H allylation